Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bitis arietans snake venom serine protease (BaSVSP) refers to a group of enzymes found in the venom of the Puff adder, a medically significant viper in Africa. These enzymes primarily disrupt the host hemostatic system by targeting the coagulation cascade, particularly through thrombin-like or fibrinogenolytic activities (PMID: 17467233). By cleaving fibrinogen, BaSVSPs can induce the formation of unstable fibrin clots or lead to the total depletion of fibrinogen, resulting in consumptive coagulopathy and severe systemic hemorrhage (PMID: 30145354). Structurally, these proteases belong to the S1 family of peptidases and utilize a conserved catalytic triad consisting of histidine, aspartate, and serine to perform their proteolytic functions. In a clinical context, BaSVSPs are the primary targets for neutralization by polyvalent antivenoms, such as the SAIMR polyvalent antivenom, which contains antibodies that bind and inactivate these toxins (PMID: 25448304). Furthermore, research into small-molecule inhibitors like nafamostat mesylate has demonstrated their potential as adjunct treatments to inhibit SVSP activity and delay the onset of systemic envenomation effects (PMID: 33035560). Their high specificity for coagulation factors also makes them valuable in diagnostic hematology and as templates for developing novel anticoagulant therapies.
Antivenoms utilize polyclonal antibodies to bind and neutralize the enzymatic activity of the proteases, while small-molecule inhibitors like nafamostat act as competitive inhibitors of the serine protease catalytic triad.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bitis arietans snake venom serine protease (BaSVSP).